Overview

Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment

Status:
Terminated
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
Plasmin is expected to create a posterior vitreous detachment. The pharmacological creation of a posterior vitreous detachment may be beneficial in a variety of conditions.
Phase:
Phase 2
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Treatments:
Fibrinolysin